At Alexion, AstraZeneca Rare Disease, we are pioneers driven by a singular mission: transforming the lives of people affected by rare diseases. For over three decades, we have been at the forefront of rare disease innovation, being the first to translate the complex biology of the complement system into transformative medicines. Our team of more than 5,000 employees across the globe operates with a relentless sense of urgency, pushing the boundaries of science to deliver life-changing therapies. We foster a collaborative culture where diverse perspectives converge to tackle the most challenging rare disease problems, always keeping patients and their families at the center of everything we do.
We believe that breakthrough therapies for rare diseases are only possible through the tireless efforts of our global community - researchers, scientists, advocates, caregivers, and most importantly, patients themselves. As part of AstraZeneca, we have expanded our potential to impact even more lives worldwide while maintaining our entrepreneurial spirit and patient-focused approach. Our values guide us: we follow the science, put patients first, play to win, do the right thing, and think entrepreneurially. Every day, we are inspired to think differently and follow the science to create better outcomes, ensuring that our work makes a meaningful difference for the rare disease community.
